NanoFUSE Bone Graft Platform
Bone regeneration in orthopedic, spine, and dental applications
ApprovedActive
Key Facts
Indication
Bone regeneration in orthopedic, spine, and dental applications
Phase
Approved
Status
Active
Company
About NanoFUSE Biologics
NanoFUSE Biologics is a commercial-stage regenerative medicine company focused on synthetic bone graft substitutes. Its core technology is a patented synthetic bioactive ceramic incorporating 45S5 Bioglass, which is FDA-cleared for spine and orthopedic bone healing procedures. The company has established a commercial footprint with a product portfolio available in moldable and flowable putty forms, featuring a 5-year shelf life and antimicrobial properties. NanoFUSE operates in the large and growing global bone graft substitute market, competing with both synthetic and biologic products.
View full company profile